Mackenzie Financial
PETX

Mackenzie Financial’s Aratana Therapeutics, Inc. PETX Stock Holding History

Mackenzie Financial’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-30,900
Closed -$261K – 850
2015
Q3 		$261K Buy
+30,900
New +$523K ﹤0.01% 751

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Mackenzie Financial's PETX Position: Q4 2015 in Review

Mackenzie Financial sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2015, closing a stake of 30,900 shares — an estimated $261K sold.

Mackenzie Financial first reported a position in PETX in Q3 2015 and held it in 1 quarter. The position peaked at $261K in Q3 2015. 98 funds tracked by Wall St. Rank hold PETX as of Q4 2015.

  • Mackenzie Financial reported no remaining Aratana Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • Mackenzie Financial sold 30,900 Aratana Therapeutics, Inc. shares in Q4 2015, an estimated $261K.
  • Mackenzie Financial first reported a position in Aratana Therapeutics, Inc. in Q3 2015 and held it in 1 quarter.
  • Mackenzie Financial's Aratana Therapeutics, Inc. position peaked at $261K in Q3 2015.
  • 98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2015.

Based on Mackenzie Financial's 13F filing for Q4 2015, filed 12 Feb 2016.